Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Détails
![Ressource 1](https://serval.unil.ch/static/img/forbidden.png)
Accès restreint UNIL
Etat: Public
Version: Final published version
ID Serval
serval:BIB_864F3EA6F2FD
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Chemotherapy is successful in sporadic late onset nemaline myopathy (SLONM) with monoclonal gammopathy.
Périodique
Muscle & nerve
ISSN
1097-4598 (Electronic)
ISSN-L
0148-639X
Statut éditorial
Publié
Date de publication
02/2010
Peer-reviewed
Oui
Volume
41
Numéro
2
Pages
286-287
Langue
anglais
Notes
Publication types: Case Reports ; Letter
Publication Status: ppublish
PDF: Letter to the editor
Publication Status: ppublish
PDF: Letter to the editor
Mots-clé
Antineoplastic Agents, Alkylating/therapeutic use, Dose-Response Relationship, Drug, Humans, Male, Melphalan/therapeutic use, Middle Aged, Myopathies, Nemaline/drug therapy, Paraproteinemias/drug therapy, Treatment Outcome
Pubmed
Web of science
Création de la notice
24/02/2010 10:54
Dernière modification de la notice
20/08/2019 15:45